| ||||||||||||||||||||||||||||||||||||||||||||
![]()
CAS号:109581-93-3
|
英文名称:Tacrolimus monohydrate
分子式
分子量
EINECS号
MDL
Smiles
InChIKey
乙二醇化学百科
基本信息
物化性质
安全信息
生产及用途
Tacrolimus monohydrate (FK506 monohydrate) 是大环内酯类化合物,Tacrolimus monohydrate 与 FK506 结合蛋白 (FKBP) 结合形成复合物并抑制钙调神经磷酸酶 (calcineurin phosphatase),从而抑制 T 淋巴细胞信号转导和 IL-2 转录。具有强免疫抑制特性。
PP2B (calcineurin phosphatase)
Tacrolimus monohydrate (FK506 monohydrate; Fujimycin monohydrate; FR900506 monohydrate) inhibits calcium-dependent events, such as IL-2 gene transcription, NO synthase activation, cell degranulation, and apoptosis. Tacrolimus also potentiates the actions of glucocorticoids and progesterone by binding to FKBPs contained within the hormone receptor complex, preventing degradation. The agent may enhance expression of the TGFβ-1 gene in a fashion analogous to that demonstrated for CsA. T cell proliferation in response to ligation of the T cell receptor is inhibited by Tacrolimus. Treatment with a low concentration of Tacrolimus (FK506,10 μg/L) does not significantly affect the proliferation of MH3924A cells (P=0.135). Upon treatment with higher concentrations of Tacrolimus (100-1,000 μg/L), the proliferation of MH3924A cells is significantly enhanced (P<0.01). Treatment with AMD3100 at any concentration (10, 50 or 100 μg/L), has no obvious effect on MH3924A cell proliferation (P>0.05). However, when different concentrations of AMD3100 are combined with 100 μg/L Tacrolimus, the in vitro proliferation of MH3924A cells is increased (P<0.01).
The therapeutic effect of Tacrolimus is investigated on progression and perpetuation of colitis by administering Tacrolimus to Dextran sulfate sodium (DSS)-treated mice from Days 10 to 16 or to 23. At Days 17 and 24, colon length is significantly shortened, and colon weight is significantly higher in DSS-treated control animals than in normal animals. In addition, colon weight per unit length in the control group is more than twice that in the normal group. While both 7 and 14 d treatment with Tacrolimus significantly suppresses increases in colon weight per unit length in DSS-treated animals compared with the control group, this treatment does not actually restore the colon shortening. In addition, this inhibitory effect of Tacrolimus on increases in colon weight per unit length is more pronounced with 14-d than 7-d treatment, as shown by the inhibitory percentages (59% vs. 28%).
上下游产品
上游产品共计:0个
下游产品共计:0个
相关产品
|
||||||||||||||||||||||||||||||||||||||||||||
本网站展示的所有产品仅用于工业制造、技术研发、科学研究,所有产品非药品不可食用,依据国家相关法规及平台管理要求,购买相关危险物品应取得有效的资质、资格条件。 参考《应急管理部等多部门关于加强互联网销售危险化学品安全管理的通知 (应急〔2022〕119号)》 和《互联网危险物品信息发布管理规定》 Copyright © 2021-2025 chemhome123版权所有 |冀ICP备2024096099号- 1|冀公安备13042302000143号|互联网增值电信业务经营许可证:冀B2-20250121 |药品、 医疗器械互联网信息服务备案凭证备案号:(冀)-非经营性-2025-0099 |